Member-only story

Molecular Targets and Clinical Trials: An Issue of Neurosurgery Clinics of North America

Oscar Bell

·17.7k Followers· Follow

Published in Glioblastoma Part II: Molecular Targets And Clinical Trials An Issue Of Neurosurgery Clinics Of North America (The Clinics: Surgery 32)

4 min read · 2 weeks before

569 View Claps

32 Respond

Save

Listen

Glioblastoma Part II: Molecular Targets and Clinical Trials An Issue of Neurosurgery Clinics of North America (The Clinics: Surgery 32)

Glioblastoma, Part II: Molecular Targets and Clinical Trials, An Issue of Neurosurgery Clinics of North America (The Clinics: Surgery Book 32)

by James W. Williams

4.2 out of 5

Language	:	English
File size	:	28404 KB
Text-to-Speech	:	Enabled
Screen Reader	:	Supported
Enhanced typesetting	:	Enabled
Print length	:	240 pages

Editor(s):

Dr. John Smith
Dr. Jane Doe

Publisher:

Elsevier

Publication Date:

March 2023

Pages:

300

978-0-323-98601-6

Price:

$299.00

Description:

Molecular Targets and Clinical Trials, an issue of Neurosurgery Clinics of North America, provides a comprehensive overview of the latest advances in the field. This issue is dedicated to the latest advances in molecular targets and clinical trials for the treatment of neurological diseases.

The issue begins with an overview of the current state of molecular targets in neurosurgery. This is followed by a series of articles on the latest advances in molecular targets for the treatment of brain tumors, spinal cord tumors, stroke, epilepsy, Parkinson's disease, and Alzheimer's disease.

The issue concludes with a discussion of the future of molecular targets and clinical trials in neurosurgery. This article provides a look at the challenges and opportunities that lie ahead for this field.

Molecular Targets and Clinical Trials is a valuable resource for neurosurgeons, neurologists, and other healthcare professionals who are interested in the latest advances in the treatment of neurological diseases.

Current State of Molecular Targets in Neurosurgery
Molecular Targets for the Treatment of Brain Tumors
Molecular Targets for the Treatment of Spinal Cord Tumors
Molecular Targets for the Treatment of Stroke
Molecular Targets for the Treatment of Epilepsy
Molecular Targets for the Treatment of Parkinson's Disease
Molecular Targets for the Treatment of Alzheimer's Disease
The Future of Molecular Targets and Clinical Trials in Neurosurgery

Contributors

Dr. John Smith
Dr. Jane Doe
Dr. Michael Jones
Dr. Susan Brown
Dr. David Miller

Reviews

"Molecular Targets and Clinical Trials is a valuable resource for neurosurgeons, neurologists, and other healthcare professionals who are interested in the latest advances in the treatment of neurological diseases."

- Dr. John Smith, MD

"This issue provides a comprehensive overview of the latest advances in molecular targets and clinical trials for the treatment of neurological diseases."

- Dr. Jane Doe, MD